Quantum Biopharma (QNTM) Raw Materials (2024 - 2025)
Quantum Biopharma (QNTM) posted Raw Materials of $55568.0 for Q3 2025, little changed sequentially from $55568.0 in Q2 2025.
Quantum Biopharma (QNTM) Raw Materials (2024 - 2025) Analysis & Trends
Quantum Biopharma has reported Raw Materials for 2 years, with the latest figure at $55568.0 in Q3 2025.
- Quarterly Raw Materials changed N/A year-over-year to $55568.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $55568.0 (changed N/A YoY) and the FY2024 annual result came in at $51973.0, changed N/A from the prior year.
- Raw Materials held at $55568.0 in Q3 2025 per QNTM's latest filing, from $55568.0 in the prior quarter.
- Over five years, Raw Materials peaked at $55568.0 in Q2 2025 and troughed at $51973.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Quantum Biopharma | 15.53 Mn | 11.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 55,568.00 |
| Jun 30, 2025 | 55,568.00 |
| Dec 31, 2024 | 51,973.00 |